Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
MRevaluation
1 other identifier
observational
108
6 countries
10
Brief Summary
The purpose of this multicenter study is to evaluate the agreement among expert radiologists in interpreting magnetic resonance images (MRI) assessing common primary liver tumours in non-cirrhotic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2010
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 3, 2010
CompletedFirst Posted
Study publicly available on registry
November 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedMay 28, 2012
May 1, 2012
1.6 years
November 3, 2010
May 25, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inter-observer agreement among expert radiologists in diagnosing primary liver tumors by Magnetic Resonance Imaging (MRI).
Inter-observer agreement for categorical data will by assessed by the Fliess' kappa (good agreement \>0.7).
December 2010
Secondary Outcomes (4)
Agreement of radiologists with the actual diagnosis of primary liver tumors assessed by Magnetic Resonance Imaging (MRI).
December 2010
Differences in radiologist' certainty of diagnosis (CoD) among different tumor types.
December 2010
Intra-class correlation coefficient among radiologists' Certainty of Diagnosis (CoD) in diagnosis primary liver tumors by Magnetic Resonant Imaging (MRI)
December 2010
Investigate the diagnostic efficacy of radiologists' certainty of diagnosis (CoD) in accurately predicting primary liver tumors assessed by Magnetic Resonant Imaging (MRI)
December 2010
Study Arms (1)
Primary liver tumors, non-cirrhotic
This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonance Imaging (MRI) and underwent resection for primary liver tumors.
Interventions
Conventional pre-operative MRI
Hepatectomy with an intention to cure
Histopathology diagnosis by expert pathologist.
Eligibility Criteria
Primary care clinics
You may qualify if:
- Histopathological diagnosis of Hepatocellular Cancer (HCC), Adenoma and/or Focular nodular hyperplasia (FNH).
- Patients that received a pre-operative Magnetic Resonance Imaging (MRI).
- Patients that underwent liver resection with an intention to cure.
- Patient over 18 years of age
You may not qualify if:
- Other histopathological diagnosis such as cysts and hemangiomas.
- Patient age less than 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Harvard Universitycollaborator
- University Hospital, Essencollaborator
- Auckland City Hospitalcollaborator
- University Hospital, Strasbourg, Francecollaborator
- The Leeds Teaching Hospitals NHS Trustcollaborator
- Imperial College Londoncollaborator
- University College London Hospitalscollaborator
- St. Louis Universitycollaborator
Study Sites (10)
Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02117-0825, United States
St. Louis University, Liver Center
St Louis, Missouri, 63110-0250, United States
University Hospital Strasbourg
Strasbourg, Cedex, 67098, France
University Hospital Essen
Essen, 45147, Germany
Auckland City Hospital
Auckland, Auckland, 9, New Zealand
University Hospital Zurich, Department of Interventional and Diagnostic Radiology
Zurich, Canton of Zurich, 8091, Switzerland
University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center
Zurich, Canton of Zurich, 8091, Switzerland
The Leeds Teaching Hospitals NHS Trust
Leeds, LS9 7TF, United Kingdom
University College London Hospitals NHS Foundation Trust
London, NW1 2PG, United Kingdom
Imperial College, Hammersmith Hospital
London, W12 0HS, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Breitenstein, MD
University Hospital Zurich, Department of Visceral and Transplant Surgery, Zurich, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2010
First Posted
November 4, 2010
Study Start
October 1, 2010
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
May 28, 2012
Record last verified: 2012-05